What is the diagnosis and treatment for Warthin's tumor?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Warthin Tumor: Diagnosis and Management

Overview and Diagnosis

Warthin tumor is a benign salivary gland neoplasm that requires surgical excision as definitive treatment, with superficial parotidectomy being the procedure of choice to minimize morbidity while preventing recurrence. 1

Warthin tumor (papillary cystadenoma lymphomatosum) is the second most common benign parotid neoplasm, accounting for approximately 15% of all parotid epithelial tumors. 1 It is almost exclusively located in the parotid gland and its environs, including parotid lymph nodes, and primarily affects middle-aged men who are often smokers. 2, 3

Diagnostic Characteristics

Histopathologic diagnosis requires two key features:

  • Oncocytic (mitochondria-rich) epithelium 3
  • Lymphoid stroma 3

Important clinical features to recognize:

  • Slow-growing, often asymptomatic mass 2, 4
  • May be multifocal and/or bilateral 5
  • Fluctuant on palpation due to cystic morphology 4
  • Predominantly affects the parotid gland, with rare occurrence in minor salivary glands 4

Diagnostic Imaging

Ultrasound should be the first-line imaging modality for evaluating parotid pathology due to its effectiveness, safety, and accessibility. 6

Dynamic MRI is particularly valuable for Warthin tumor as it demonstrates a characteristic pattern of rapid enhancement followed by rapid attenuation on gadolinium uptake, which can prevent misdiagnosis as malignancy. 2 This is critical because fine needle aspiration cytology (FNAC) occasionally misdiagnoses Warthin tumors as squamous cell carcinoma or acinic cell carcinoma. 2

For suspected tumors or complex cases, MRI with contrast provides superior soft tissue resolution and should be used for accurate preoperative tumor localization. 6

Genetic Markers

The t(11;19)(q21;p13) translocation involving MECT1/MAML2 genes has been identified in Warthin tumor, though this is a benign finding. 7

Treatment Approach

Surgical Management

The treatment of choice is complete surgical excision with preservation of the facial nerve. 1

Recommended surgical procedures based on tumor location:

  • For superficial lobe tumors: Perform superficial (subtotal) parotidectomy 5, 1
  • For deep lobe tumors: Enucleation is appropriate 5
  • When tumor capsule directly contacts facial nerve: Use enucleative procedure at the tumor base 5

Superficial parotidectomy is preferred over total parotidectomy because while total parotidectomy theoretically reduces recurrence risk through more radical resection, superficial parotidectomy is equally effective with significantly lower morbidity in terms of facial nerve dysfunction and Frey's syndrome. 1

Important Surgical Considerations

Critical pitfalls to avoid:

  • Do NOT perform simultaneous bilateral parotid surgery if bilateral tumors are present, as this risks bilateral facial nerve palsy 5
  • Exercise extra caution with multiple tumors or deep lobe tumors, as these have higher rates of facial nerve complications 5
  • Capsule rupture during surgery does not necessitate more aggressive resection - no recurrences have been observed even when capsular rupture occurred 5

Expected Outcomes

Recurrence rates: Zero recurrence after appropriate surgical excision with long-term follow-up 5, 1

Complications to anticipate:

  • Facial nerve dysfunction: Most common complication, occurring in 47.2% of cases, with the marginal mandibular branch affected in 95.8% of facial nerve injuries 1
  • Temporary facial nerve palsy: 19.7% incidence 5
  • Permanent facial nerve palsy: 0% with careful technique 5
  • Frey's syndrome: 17.6% in late postoperative period 1

Malignant Transformation

Malignant Warthin tumors are extremely rare and represent either carcinomas arising from the ductal component or non-Hodgkin's lymphomas arising from the lymphoid tissue. 3 If malignancy is suspected based on imaging or clinical features, prompt referral for biopsy and definitive management including surgery with potential postoperative radiotherapy is indicated. 6

Role of Conservative Management

Conservative management has no role in definitive treatment of Warthin tumor. While conservative measures (warm compresses, hydration, massage, sialagogues, antibiotics) may be appropriate for inflammatory salivary conditions like sialadenitis 6, Warthin tumor requires surgical excision for cure.

References

Research

Warthin's tumour of the parotid gland: our experience.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2013

Research

Correct diagnosis of Warthin tumor in the parotid gland with dynamic MRI.

The Tohoku journal of experimental medicine, 2012

Research

Warthin's tumor.

The Annals of otology, rhinology, and laryngology, 1990

Research

Papillary cystoadenoma lymphomatosum (Warthin-like) of minor salivary glands.

Medicina oral, patologia oral y cirugia bucal, 2009

Research

[Surgical procedure for Warthin's tumor in the parotid gland].

Nihon Jibiinkoka Gakkai kaiho, 2005

Guideline

Management of Swollen Submandibular Gland

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.